seen heaps of test kits come out, or coming, with various biomarkers- the more markers (indicators) the better.
instant saw this as a huge market for BRN,
risk factor is if those test kits can already do a good enough job (as many quote 99%) would there be a need to convert over to BRN, my thoughts are yes, as why would a company be bound by one test outcome, the competition will over run their product.. so are doing multiple indicator for whether infection as virual or bacterial? done fast - directed treatment to exact issue can have huge benefits. we all see "if treated early"
actually i see this area of medicine as bigger that other areas of application for BRN, ... those collaborations with sensor companies are a major focus to putting these things into practice to = $
NANOSE & SNIFFPHONE, page-11
-
- There are more pages in this discussion • 1,484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.1M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $656.1K | 3.281M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 364081 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 1348618 | 18 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |